Common epilepsy drug levetiracetam presents potential clot risk for patients taking blood thinners
Researchers from the University of Liverpool and the University of Zurich have identified a potential safety consideration involving levetiracetam, one of the world's most commonly prescribed antiseizure medications.
Sep 14, 2026
0
3








